Mario Fernando Mendez MD PhD
Director of Neurobehavior at the VA Greater Los Angeles and Professor of Neurology and Psychiatry at UCLA Director of the Focal-type Dementia Clinic and Program
Join to View Full Profile
300 Medical Plz# B200Los Angeles, CA 90095
Phone+1 310-794-1195
Fax+1 310-794-7491
Dr. Mendez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 1979 - 1983
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1974 - 1978
University of Texas Medical Branch School of MedicineClass of 1974
Certifications & Licensure
CA State Medical License 1975 - 2026
MN State Medical License 1989 - 2000
OH State Medical License 1985 - 1994
TX State Medical License 1974 - 1981
American Board of Internal Medicine Internal Medicine
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls Start of enrollment: 2010 Jan 01
Publications & Presentations
PubMed
- Functional Connectivity Associations With Markers of Disease Progression in GRN Pathogenic Variant Carriers.Taru M Flagan, Stephanie A Chu, Suvi Häkkinen, Liwen Zhang, David McFall
Annals of Clinical and Translational Neurology. 2025-09-16 - 1 citationsAmyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts.Julien Lagarde, Piyush Maiti, Daniel R Schonhaut, Ganna Blazhenets, Jiaxiuxiu Zhang
Annals of Neurology. 2025-08-01 - 3 citationsLarge-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration.Rowan Saloner, Adam M Staffaroni, Eric B Dammer, Erik C B Johnson, Emily W Paolillo
Nature Aging. 2025-06-01
Press Mentions
NKGen Biotech Announces Administration of First Dose of Troculeucel to Frontotemporal Dementia Patient Under FDA-Cleared Compassionate Use ProgramFebruary 21st, 2025- What Is Frontotemporal Dementia? The Disease Afflicting Actor Bruce Willis Is IncurableFebruary 17th, 2023
- The Relationship Between Head Injury and Dementia Risk: Why It’s ComplicatedNovember 19th, 2021
- Join now to see all
Grant Support
- Multidisciplinary Study Of Social Behavior And Emotion In Frontotemporal DementiaNational Institute On Aging2009–2011
- Functional-Behavior Correlates Between Alzheimer'S Disease And FrontotemporalNational Center For Research Resources2005–2008
- Functional-Behavior Correlates In AD And FrontotemporalNational Center For Research Resources2004
Other Languages
- French, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
